hsa-mir-4651: Hsa-mir-4651 is a microRNA that has been implicated in various biological processes and diseases. It has been predicted to target several genes in different contexts. In gestational diabetes mellitus (GDM), hsa-mir-4651 was found to target the gene FYN [PMC8145272]. In Alport syndrome, hsa-mir-4651 was found to be upregulated in iPSCs from patients [PMC7998154]. In liver fibrosis, hsa-mir-4651 was identified as one of the upregulated miRNAs [PMC5039723]. In non-small-cell lung cancer, hsa-mir-4651 was found to inhibit cancer progression by targeting BRD4 [PMC7347495]. Additionally, hsa-mir-4651 has been implicated in HIV infection and HIV-associated diseases [PMC4865051]. It is worth noting that hsa-mir-4651 is not the only miRNA of interest in these contexts, as several other miRNAs have also been identified as potential regulators of gene expression. These findings highlight the complexity and diversity of miRNA-mediated gene regulation.